1 Comment

Hi Sally!

Sorry it's been a while since I last replied to one of your articles. After subscribing, google strangely needed a cellphone number to the account to sign in to your newsletter. I think I've skirted around this for now.

Anyway, I was perplexed looking at Table 2. Distribution of AE's from the Philippines FDA Pharmacovigilance report. I downloaded the report and indeed it states COMIRNATY!

I'm seriously troubled by this as there seems to be a deliberate attempt to bait with an FDA-approved shot but inject the Emergency Use Authorized product instead.

Source: https://pa.childrenshealthdefense.org/news/ghost-shot-pfizer-quietly-admits-it-will-never-manufacture-original-fda-approved-covid-vaccines/

-------

In May, Pfizer updated its statement to mention a December 2021 licensed Comirnaty product, which was granted a license four months after the highly-publicized August FDA press release.

And just last week, Pfizer finally acknowledged that its original licensed product will never be distributed. In an unreported update on the CDC website, Pfizer told the agency:

“Pfizer received initial FDA BLA license on 8/23/2021 for its COVID-19 vaccine for use in individuals 16 and older (COMIRNATY). At that time, the FDA published a BLA package insert that included the approved new COVID-19 vaccine tradename COMIRNATY and listed 2 new NDCs (0069-1000-03, 0069-1000-02) and images of labels with the new tradename. These NDCs will not be manufactured. Only NDCs for the subsequently BLA approved tris-sucrose formulation will be produced.”

-----------

I also observed that page 4 (Phil. FDA PharmaCoV report) lists the said shot as:

-----

At present, the FDA granted nine (9) COVID-19 vaccines with emergency use authorization:

● Pfizer-BioNTech COVID-19 mRNA Vaccine (nucleoside modified) [Comirnaty]

------

IT CANNOT BE BOTH THE EUA PFIZER SHOT AND FDA APPROVED COMIRNATY at the same time! This is clearly the Pfizer Shot under EUA.

What is this then? Dare I say that this report is fraudulent?

Expand full comment